Path/Lab Coding:
Beware Payer Bundling for Multiple STI NAAT Tests
Published on Thu Oct 30, 2025
Know when payer policy overrides CPT®, NCCI rules. Consider the following scenario, common to laboratories across the country: A clinician suspects their patient has a sexually transmitted infection (STI) and orders testing for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis to try to identify the infectious agent responsible. Your lab performs nucleic acid amplification tests (NAAT) for each of those organisms, which you bill [...]